HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Georgios K. Kanellopoulos Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kanellopoulos, G. K. Articles by Kvernebo, K. Search for Related Content PubMed PubMed Citation Articles by Kanellopoulos, G. K. Articles by Kvernebo, K.

Eur J Cardiothorac Surg 1999;16:135-143
© 1999 Elsevier Science NL

Transventricular non-transmural laser treatment of hypoperfused porcine myocardium acutely reduces left ventricular contractile function

^a Institute for Experimental Medical Research, Ullevaal University Hospital, University of Oslo, Oslo, Norway
^b Department of Cardiothoracic Surgery, Ullevaal University Hospital, University of Oslo, Oslo 0407, Norway
^c Department of Pathology, Ullevaal University Hospital, University of Oslo, Oslo, Norway

Corresponding author. Tel.: +47-22-119500; fax: +47-22-117470.

Objective: Creation of non-transmural myocardial channels by lasers transmitted through endovascular fiberoptics is a novel therapeutic option in the management of patients with coronary artery disease. The acute effect of transventricular laser treatment (TvL) on coronary blood flow, myocardial metabolism and left ventricular function are not well established. Methods: In five anesthetized pigs, flow in the proximal left anterior descending coronary artery (LAD) was reduced and maintained at 70% of baseline. A venous shunt had previously been established draining the hypoperfused region. At 30 min of ischemia, non-transmural myocardial channels were created through the endocardium using a Ho:YAG laser. We measured (a) left ventricular, central venous and arterial pressures, (b) ascending aortic, LAD and coronary venous blood flows, as well as (c) lactate concentration and blood gases in arterial and coronary venous blood, prior to ischemia (baseline), before and 30 min after TvL. Data (given as mean±SD) were analyzed with repeated measures ANOVA. Results: Reduction of LAD blood flow resulted in reduced regional coronary venous blood flow and myocardial oxygen consumption, conversion of regional myocardial lactate uptake to release and adaptation of left ventricular contractility to a lower level. Following transventricular laser, the peak left ventricular systolic pressure declined from 86±12 to 77±11 mmHg (P<0.05), its maximal first positive derivative (LV dP/dt) declined from 900±221 to 763±127 mmHg/s (P<0.05) and the stroke volume decreased from 19.2±4.1 to 16.4±5.4 ml (P<0.05). The changes in regional coronary venous flow, myocardial oxygen consumption and myocardial lactate release after TvL were not significant compared to before TvL. Significant intramural hematomas and tissue destruction were found around the channels at autopsy and by histologic examination. Conclusion: Transventricular laser treatment of hypoperfused myocardium decreased left ventricular contractility in the acute phase, possibly due to development of perichannel hematomas and disruption of the wall architecture. In addition, TvL did not alter the regional myocardial oxygen supply/demand balance. These results call for caution in the treatment of patients with coronary artery disease by transventricular Ho-YAG laser when there is significant impairment of the left ventricular contractile function.

Key Words: Metabolism • Myocardial ischemia • Coronary circulation • Oxygen consumption • Regional blood flow • Pig • Angina pectoris